AbCellera Biologics logo

AbCellera Biologics

Vancouver-based company focused on antibody discovery for therapeutics and immune profiling for vaccine research.

11

Funding Rounds

$378.9m

Money raised

Overview

Vancouver-based company focused on antibody discovery for therapeutics and immune profiling for vaccine research.

Funding

Funding series

Funding Series Analysis

The company AbCellera Biologics has raised a total of $296.22m in funding over 11 rounds.

Key Insights:

  • AbCellera Biologics Series B round, May 27, 2020: $105m
  • AbCellera Biologics Grant (money), May 3, 2020: $175.6m
  • AbCellera Biologics Grant (money), May 14, 2019: $4.8m
  • AbCellera Biologics Series A round: $10m
  • AbCellera Biologics venture round, April 2017 : $817.9k
  • AbCellera Biologics Inc. funding round, May 2020: $74.5m
  • AbCellera Biologics Inc. funding round, August 2018: $7.7m
  • AbCellera Biologics Inc. funding round, March 2018: $484.48k
AbCellera Biologics logo
AbCellera Biologics Series B round, May 27, 2020 $105m
AbCellera Biologics logo
AbCellera Biologics Grant (money), May 3, 2020 $175.6m
AbCellera Biologics logo
AbCellera Biologics Grant (money), May 14, 2019 $4.8m
AbCellera Biologics logo
AbCellera Biologics Series A round $10m
AbCellera Biologics logo
AbCellera Biologics venture round, April 2017 $817.9k
AbCellera Biologics logo
AbCellera Biologics Inc. funding round, May 2020 $74.5m
AbCellera Biologics logo
AbCellera Biologics Inc. funding round, August 2018 $7.7m
AbCellera Biologics logo
AbCellera Biologics Inc. funding round, March 2018 $484.48k

Industries

AbCellera Biologics is active in the following industries:
  • Pharmaceutical industry
  • Immunotherapy
  • Healthcare
  • Biotechnology
  • Biomedical engineering
  • Biology
  • Technology
  • Vaccine
  • Drug discovery
  • Drug development
  • Engineering
  • Consumer biotechnology